Nox4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NOX4 (NADPH Oxidase 4) is a gene located on chromosome 11q14.3 that encodes NADPH oxidase 4, a constitutively active member of the NADPH oxidase (NOX) family of enzymes[^1]. Unlike other NOX isoforms that primarily produce superoxide anion (O₂⁻), NOX4 predominantly generates hydrogen peroxide (H₂O₂), which has distinct signaling properties and cellular effects.
NOX4 has complex and context-dependent roles in neurodegeneration. It is expressed in neurons, astrocytes, microglia, and endothelial cells within the brain, where it contributes to both physiological signaling and pathological processes[^2]. Its constitutive activity and H₂O₂ production make it unique among NOX enzymes.
| NADPH Oxidase 4 |
|---|
| Gene Symbol | NOX4 |
| Full Name | NADPH Oxidase 4 |
| Chromosome | 11q14.3 |
| NCBI Gene ID | 50507 |
| OMIM | 605966 |
| Ensembl ID | ENSG00000188882 |
| UniProt ID | Q9NPH5 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Diabetic Neuropathy, Stroke |
¶ Gene Structure and Protein Architecture
NOX4 encodes a protein of approximately 578 amino acids with a molecular weight of ~67 kDa. The protein architecture differs from other NOX isoforms:
- N-terminal transmembrane domains (6×): Span the membrane and contain heme-binding sites
- Dehydrogenase domain: Located in the cytoplasm, contains FAD and NADPH binding sites
- C-terminal tail: Regulatory elements for protein interactions
- Constitutive activity: NOX4 does not require regulatory subunits (p47phox, p67phox, Rac) for activity
- H₂O₂ production: Primary product is hydrogen peroxide rather than superoxide
- ER localization: Much of NOX4 activity occurs in the endoplasmic reticulum
NOX4 generates H₂O₂ through a two-step process:
NADPH → FAD → heme → O₂ → O₂⁻ → SOD → H₂O₂
- Cell signaling: H₂O₂ acts as a second messenger in various signaling pathways
- Hypoxia response: NOX4 is upregulated by hypoxia and contributes to adaptive responses
- Differentiation: Supports neuronal differentiation processes
- Angiogenesis: Promotes blood vessel formation in development and repair
In the central nervous system, NOX4 is expressed in:
- Astrocytes: High expression, particularly in reactive astrocytes
- Neurons: Moderate expression, especially in cortical and hippocampal neurons
- Microglia: Inducible expression upon activation
- Endothelial cells: Contributes to blood-brain barrier function
NOX4 has dual, context-dependent roles in AD[^3]:
Potentially Beneficial Effects:
- H₂O₂ can promote α-secretase activity, increasing non-amyloidogenic APP processing
- May support amyloid clearance through adaptive stress responses
- Low-level ROS can activate antioxidant defense pathways
Potentially Harmful Effects:
- Chronic oxidative stress damages neurons
- Can contribute to Aβ-induced toxicity
- Promotes neuroinflammation through glial activation
- May exacerbate tau pathology
The balance between these effects likely depends on NOX4 expression levels, cellular context, and disease stage[^4].
In PD, NOX4 generally promotes pathology[^5]:
- Dopaminergic neuron vulnerability: NOX4-generated ROS damages vulnerable SNc neurons
- α-Synuclein aggregation: Oxidative stress promotes protein misfolding
- Mitochondrial dysfunction: NOX4 can impair complex I activity
- Neuroinflammation: Astrocyte NOX4 amplifies inflammatory responses
¶ Stroke and Ischemia
NOX4 is strongly upregulated following ischemic injury:
- Acute phase: Contributes to reperfusion injury through ROS burst
- Blood-brain barrier disruption: MMP activation via NOX4-derived ROS
- Infarct expansion: Mediates secondary neuronal death
NOX4 plays a key role in diabetic complications:
- Hyperglycemia-induced ROS: NOX4 is activated by high glucose
- Schwann cell dysfunction: Impairs peripheral nerve myelination
- Neuronal damage: Contributes to sensory neuron loss
| Stimulus |
Effect |
Mechanism |
| Hypoxia |
↑↑↑ |
HIF-1α dependent |
| TGF-β |
↑ |
SMAD signaling |
| Hyperglycemia |
↑ |
PKC activation |
| Inflammatory cytokines |
↑ |
NF-κB dependent |
| Shear stress |
↑ |
MAPK pathways |
- MAPK pathways: ERK1/2, JNK, p38 activation
- NF-κB: Pro-inflammatory gene expression
- Nrf2: Antioxidant response element activation
- Akt/mTOR: Growth and survival signaling
| Compound |
Specificity |
Development Stage |
| GKT137831 |
NOX1/NOX4 |
Phase 2 (diabetic nephropathy) |
| GKT831 |
NOX1/NOX4 |
Phase 2 (IPF) |
| VAS2870 |
Pan-NOX |
Preclinical |
- Context matters: NOX4 inhibition may be beneficial in some conditions but harmful in others
- Timing: Acute vs. chronic NOX4 inhibition may have different effects
- Combination therapy: May need to combine with antioxidants or anti-inflammatory agents
NOX4 activity can be assessed through:
- Direct measurement: Amplex Red assay for H₂O₂
- Gene expression: NOX4 mRNA levels in blood or tissue
- Indirect markers: 4-HNE adducts, 8-OHdG in CSF
- Imaging: NOX4-targeted PET ligands in development
- POLD1: DNA polymerase delta subunit, potential NOX4 interactor
- Hsp90: Chaperone for NOX4 stability
- EAAT2/GLT-1: Astrocytic glutamate transporter, regulated by NOX4
- Nrf2-ARE pathway: H₂O₂ can activate Nrf2, inducing antioxidant genes
- NF-κB pathway: Reciprocal activation with NOX4
- mTOR pathway: NOX4 can influence autophagy through mTOR modulation
The study of Nox4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bedard & Krause, The NOX family of ROS-generating NADPH oxidases (2007), Physiol Rev 87:245-313
- Sorce & Krause, NOX enzymes in the central nervous system (2009), J Neurochem 109:1-12
- Park et al., NOX4 in Alzheimer's disease (2014), Neurobiol Aging 35:1793-1802
- Hu et al., Dual role of NOX4 in neurodegeneration (2015), Free Radic Biol Med 86:331-342
- Sato et al., NOX4 in Parkinson's disease (2014), Neuroscience 271:123-130
- Hernansanz-Agustín et al., NOX4 in hypoxia and ischemia (2014), Free Radic Biol Med 76:251-265
- Cai et al., NOX4 in diabetic neuropathy (2015), Neuropharmacology 95:222-231
- Kim et al., GKT137831 in Parkinson's disease models (2017), Neuropharmacology 117:92-104